Today, doctors are increasingly looking at the genetic makeup of each patient’s tumor to guide treatment decisions.

Tissue Cryopreservation Preserves More Future Options The way a patient's tumor tissue is preserved after surgery is ...

Leah Phillips was diagnosed with Stage 4 lung cancer at 43. She never smoked, but a genetic mutation allowed the cancer to ...

The U.S. Food and Drug Administration (FDA) has granted plixorafenib a Breakthrough Therapy Designation, signaling ...

Screening rules are too narrow and keep patients from receiving care until it’s too late, say many Boston-area researchers ...

It's the deadliest cancer in the US, killing about 125,000 annually. As more fit, healthy people receive the devastating ...

Fred Hutch at AACR: Colorectal cancer and glyphosate exposure, potential therapeutic targets for ovarian cancer, a new molecular standard of care for cancer patients — and more ...

Lantern Pharma Inc. ( LTRN) Shareholder/Analyst Call April 9, 2026 8:30 AM EDT ...

Introduction Skin rash is the most common adverse effect in patients with cancer receiving epidermal growth factor receptor inhibitors (EGFRIs), which can impair quality of life and lead to treatment ...

For most patients diagnosed with kidney cancer, the standard playbook is clear. Immunotherapy and targeted therapies directed ...

A study found that in about 10 percent of patients, WGS picked up on clinically actionable information other panels missed.

Black Diamond Therapeutics, Inc. BDTX is building its equity story around a single, high-leverage asset: silevertinib, a ...